Skip Navigation


Rheumatology Advance Access originally published online on March 9, 2006
Rheumatology 2006 45(9):1087-1095; doi:10.1093/rheumatology/kel061
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
45/9/1087    most recent
kel061v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Decker, P.
Right arrow Articles by Rammensee, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Decker, P.
Right arrow Articles by Rammensee, H.-G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus

Patrice Decker1,, Ina Kötter2, Reinhild Klein2, Beate Berner2 and Hans-Georg Rammensee1

1Institute for Cell Biology, Department of Immunology, University of Tübingen and2Internal Medicine II, University Hospital, Tübingen, Germany.

Correspondence to: Dr Patrice Decker, Institute for Cell Biology, Department of Immunology, Auf der Morgenstelle 15, D-72076, Tübingen, Germany. E-mail: patrice.decker{at}uni-tuebingen.de

Objectives. Dendritic cells (DCs) play a key role in regulating immune responses, especially in priming naïve T-cells. Recently, DCs have been suggested to be involved in systemic lupus erythematosus (SLE) development by activating autoreactive T-helper lymphocytes. As a consequence, we compared the activation state of human monocyte-derived DCs (MDDCs) obtained from lupus patients and normal individuals.

Methods. The MDDCs were generated in vitro from blood from healthy donors and lupus patients. Immature and mature MDDCs were analysed by flow cytometry for several cell surface molecules. In parallel, cytokine secretion was determined by ELISA before and after MDDC activation. In each experiment, lupus DCs were compared with normal DCs.

Results. Here, we show for the first time that lupus MDDCs spontaneously over-express CD86 in the absence of any DC activation signal as compared with normal MDDCs (P=0.025). Moreover, activation-induced IL-6 secretion was increased in lupus DCs with high CD86 over-expression as compared with normal DCs (P=0.010). Interestingly, the percentage of MDDCs in lupus preparations is negatively correlated with disease activity scores (SLEDAI; P=0.031).

Conclusions. Lupus MDDCs are pre-activated suggesting that they might be more efficient antigen-presenting cells. This result might partly explain how the peripheral tolerance is broken in SLE.

KEY WORDS: CD86 over-expression, Monocyte-derived dendritic cell, Lupus, Dendritic cell maturation, Peripheral tolerance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. C. Crispin, M. Oukka, G. Bayliss, R. A. Cohen, C. A. Van Beek, I. E. Stillman, V. C. Kyttaris, Y.-T. Juang, and G. C. Tsokos
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
J. Immunol., December 15, 2008; 181(12): 8761 - 8766.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Mozaffarian, A. E. Wiedeman, and A. M. Stevens
Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1
Rheumatology, September 1, 2008; 47(9): 1335 - 1341.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.